belimumab

belimumab Structure
CAS No.
356547-88-1
Chemical Name:
belimumab
Synonyms
belimumab;LymphoStat B;Belimumab (anti-TNFSF13B);Anti-Human BAFF(Belimumab);Research Grade Belimumab(DHJ85301)
CBNumber:
CB31856030
Molecular Formula:
Molecular Weight:
0
MOL File:
Mol file
Modify Date:
2024/7/2 8:55:05

belimumab Properties

storage temp. Store at 4°C, do not freeze
form Solid
color White to off-white

belimumab Chemical Properties,Uses,Production

Description

Belimumab was approved by the U.S. FDA in March 2011 for treatment of patients with active, autoantibody-positive, systemic lupus erythematosus (SLE). Belimumab is a human sequence monoclonal antibody that binds to human B lymphocyte stimulator protein (BLys; also known as BAFF, THANK, TALL-1, TNFSF13B, and zTNF4), which is overexpressed in SLE patients. BLys is expressed on the cell surface of monocytes, macrophages, and monocyte-derived dendritic cells and is cleaved to form a soluble cytokine that stimulates cell proliferation and antibody secretion in B lineage cells that express the BLys receptor BAFF-R (also known as BR-3). The precise function of two additional BLys receptors, TACI and BCMA, is less clear. Belimumab inhibits BLys interaction with these three receptors leading to measurable reductions in autoantibodies, such as anti-dsDNA, and specific circulating B cell lineage compartments including antibody producing plasma cells. Belimumab was discovered by screening molecules from a phage display library of human single-chain Fv sequences for BLys binding and functional blocking, followed by optimization of the lead through the introduction of variant residues in VH CDR3.

Uses

Treatment of autoimmune disease.

belimumab Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 16)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21671 55 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826 China 48467 58 Inquiry
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 China 1566 58 Inquiry
AntibodySystem 17762345272 18162686757 China 9817 58 Inquiry
TargetMol Chemicals Inc. 15002134094 China 28118 58 Inquiry
Changsha Fuzhen Biotechnology Co.,LTD 0731-13823398 13823398779 China 3104 58 Inquiry
Shanghai jerryxing Biomedical Technology Co., Ltd 17721492509 China 5347 58 Inquiry
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 China 10022 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd 029-81124267 15229202216 China 10011 58 Inquiry
belimumab Anti-Human BAFF(Belimumab) Research Grade Belimumab(DHJ85301) Belimumab (anti-TNFSF13B) LymphoStat B 356547-88-1